A business in context
LGND research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-22 | Zimmermann Martine | F · Tax / exercise payment | Common Stock | 115.0 | 298.5 |
| 2026-09-10 | Zimmermann Martine | S · Sale | Common Stock | 1200.0 | 285.0 |
| 2026-09-03 | Reardon Andrew | S · Sale | Common Stock | 385.0 | 287.53 |
| 2026-09-03 | Reardon Andrew | S · Sale | Common Stock | 1800.0 | 285.17 |
| 2026-09-03 | Reardon Andrew | S · Sale | Common Stock | 2115.0 | 286.36 |
| 2026-09-03 | Reardon Andrew | S · Sale | Common Stock | 300.0 | 283.99 |
| 2026-09-03 | Reardon Andrew | S · Sale | Common Stock | 400.0 | 288.98 |
| 2026-08-12 | Espinoza Octavio | M · Exercise / conversion | Common Stock | 16179.0 | 52.84 |
| 2026-08-12 | Espinoza Octavio | M · Exercise / conversion | Common Stock | 3348.0 | 68.74 |
| 2026-08-12 | Espinoza Octavio | M · Exercise / conversion | Common Stock | 7171.0 | 57.22 |
| 2026-08-12 | Espinoza Octavio | S · Sale | Common Stock | 31641.0 | 292.07 |
| 2026-08-12 | Espinoza Octavio | M · Exercise / conversion | Common Stock | 2074.0 | 70.04 |
| 2026-08-12 | Espinoza Octavio | M · Exercise / conversion | Common Stock | 2869.0 | 55.75 |
| 2026-08-12 | Espinoza Octavio | M · Exercise / conversion | Non-Qualified Stock Option (right to buy) | 2074.0 | 0.0 |
| 2026-08-12 | Espinoza Octavio | M · Exercise / conversion | Employee Stock Option (right to buy) | 2869.0 | 0.0 |
| 2026-08-12 | Espinoza Octavio | M · Exercise / conversion | Non-Qualified Stock Option (right to buy) | 16179.0 | 0.0 |
| 2026-08-12 | Espinoza Octavio | M · Exercise / conversion | Non-Qualified Stock Option (right to buy) | 3348.0 | 0.0 |
| 2026-08-12 | Espinoza Octavio | M · Exercise / conversion | Employee Stock Option (right to buy) | 7171.0 | 0.0 |
| 2026-08-12 | Haas Jason | M · Exercise / conversion | Common Stock | 6138.0 | 51.56 |
| 2026-08-12 | Haas Jason | S · Sale | Common Stock | 7138.0 | 292.81 |
| 2026-08-12 | Haas Jason | M · Exercise / conversion | Non-Qualified Stock Option (right to buy) | 6138.0 | 0.0 |
| 2026-08-03 | Reardon Andrew | S · Sale | Common Stock | 200.0 | 290.6 |
| 2026-08-03 | Reardon Andrew | S · Sale | Common Stock | 991.0 | 291.71 |
| 2026-08-03 | Reardon Andrew | S · Sale | Common Stock | 409.0 | 292.82 |
| 2026-08-03 | Reardon Andrew | M · Exercise / conversion | Common Stock | 5000.0 | 52.27 |
| 2026-08-03 | Reardon Andrew | S · Sale | Common Stock | 105.0 | 284.14 |
| 2026-08-03 | Reardon Andrew | S · Sale | Common Stock | 33.0 | 284.55 |
| 2026-08-03 | Reardon Andrew | S · Sale | Common Stock | 157.0 | 285.74 |
| 2026-08-03 | Reardon Andrew | S · Sale | Common Stock | 1032.0 | 286.8 |
| 2026-08-03 | Reardon Andrew | S · Sale | Common Stock | 1214.0 | 287.77 |
| 2026-08-03 | Reardon Andrew | S · Sale | Common Stock | 356.0 | 288.75 |
| 2026-08-03 | Reardon Andrew | S · Sale | Common Stock | 503.0 | 289.8 |
| 2026-08-03 | Reardon Andrew | M · Exercise / conversion | Employee Stock Option (right to buy) | 5000.0 | 0.0 |
| 2026-07-01 | Reardon Andrew | S · Sale | Common Stock | 600.0 | 317.15 |
| 2026-07-01 | Reardon Andrew | S · Sale | Common Stock | 900.0 | 315.78 |
| 2026-07-01 | Reardon Andrew | S · Sale | Common Stock | 100.0 | 314.58 |
| 2026-07-01 | Reardon Andrew | S · Sale | Common Stock | 700.0 | 313.46 |
| 2026-07-01 | Reardon Andrew | S · Sale | Common Stock | 1081.0 | 312.28 |
| 2026-07-01 | Reardon Andrew | S · Sale | Common Stock | 1119.0 | 311.72 |
| 2026-07-01 | Reardon Andrew | S · Sale | Common Stock | 104.0 | 310.2 |
| 2026-07-01 | Reardon Andrew | S · Sale | Common Stock | 396.0 | 308.99 |
| 2026-07-01 | Reardon Andrew | M · Exercise / conversion | Common Stock | 5000.0 | 52.27 |
| 2026-07-01 | Reardon Andrew | M · Exercise / conversion | Employee Stock Option (right to buy) | 5000.0 | 0.0 |
| 2026-06-30 | Reardon Andrew | J · Other (see filing) | Common Stock | 132.0 | 160.71 |
| 2026-06-30 | Espinoza Octavio | J · Other (see filing) | Common Stock | 17.0 | 160.71 |
| 2026-06-30 | Davis Todd C | J · Other (see filing) | Common Stock | 132.0 | 160.71 |
Identity & relationships
SEC issuer · 0000886163LIGAND PHARMACEUTICALS INC
Search names and former names
- LIGAND PHARMACEUTICALS · former SEC name · 1994-09-13 to 1994-09-13
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $167.13M | $179.52M |
| 2023-12-31 | $131.31M | $145.20M |
| 2022-12-31 | $196.25M | $225.90M |
| 2021-12-31 | $241.54M | $300.30M |
| 2020-12-31 | $163.56M | $212.94M |
| 2019-12-31 | $120.28M | $158.51M |
| 2018-12-31 | $251.45M | $337.39M |
| 2017-12-31 | $141.10M | $193.95M |